Author: Ben Adams

The government is looking to make it easier to allow pharma firms to use patented drugs in clinical trials in the hope of making the UK more attractive to researchers.

AstraZeneca’s new chief executive Pascal Soriot (pictured) endures a baptism of fire as third quarter sales dip by 15 per cent.

AstraZeneca and Ironwood have teamed up to get the world’s first drug for irritable bowel syndrome onto the Chinese market.

In the latest in its series of digital club meetings PharmaTimes asked ‘Why should your boss support digital initiatives?’ at the Park Plaza Westminster Bridge in London. The resounding answer was: Bosses need to see results, so do your research when trying to get a budget for a new digital scheme signed off.

UCB says that pharma-university collaborations can help the UK economy flourish.